Can VR games boost brain and body health in schizophrenia?
NCT ID NCT07173465
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether virtual reality training or physical activity could improve physical function, thinking, and quality of life in 45 adults with schizophrenia. Participants did either VR gaming or structured exercise for 12 weeks. Researchers measured balance, walking ability, memory, and daily living skills to see which approach works better.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Virtual reality training and physical activity
- What this could lead to
- If effective, these interventions could offer new, non-drug ways to improve balance, thinking, and daily life for people with schizophrenia.
- What could go wrong
- This is a small, completed study with only 45 participants, so results may not apply widely. The interventions are short-term and may not produce lasting benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
45 people
The number who actually took part.
- Started
-
May 2023
- Finished
-
Aug 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 77 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Between the ages of 20 and 77 years old. * Willing to participate in research. * Diagnosed with Schizophrenia according to the criteria defined in the DSM-IV by a psychiatrist. * Able to attend Community Mental Health Center regularly. * Not diagnosed with a mental disability, alcoholism, or drug addiction. * Scoring 40 points or higher on the GAF test, indicating a non-severe mental state. * Capable of fully understanding the purpose and content of the research. * Able to participate in physical activity that requires musculoskeletal movement without difficulty, as determined by self-report. Exclusion Criteria: * Have significant cardiovascular, neuromuscular, endocrine, or other disorders that might prevent safe participation in the study. * Have a diagnosis of alcohol or substance abuse. * Have a secondary diagnosis of neurological disease or disease associated with the consumption of toxins, addiction to technology, or compulsive gambling. * Unable to read, understand, or respond to assessment tests.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Balance; distorted are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kartal Dr Lutfi Kirdar City Hospital
Istanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can virtual reality make memory therapy more powerful?
- Scientists probe brain's reward system in mental illness
- New schizophrenia drug targets brain glutamate, not dopamine
- New drug candidate takes aim at schizophrenia symptoms
- New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
- Can a tuned brain implant sharpen thinking in Parkinson's?